National Research Corp. (NASDAQ:NRCIB) CEO Michael D. Hays sold 3,533 shares of the stock in a transaction that occurred on Monday, September 19th. The shares were sold at an average price of $16.19, for a total transaction of $57,199.27. Following the sale, the chief executive officer now directly owns 6,467,744 shares of the company’s stock, valued at approximately $104,712,775.36. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Shares of National Research Corp. (NASDAQ:NRCIB) opened at 36.1811 on Thursday. The stock has a 50 day moving average of $33.92 and a 200-day moving average of $35.16. National Research Corp. has a 1-year low of $31.36 and a 1-year high of $44.60. The firm has a market cap of $876.34 million, a price-to-earnings ratio of 44.4485 and a beta of 0.28.
National Research Corp. (NASDAQ:NRCIB) last announced its quarterly earnings data on Tuesday, August 2nd. The company reported $0.18 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.18. National Research Corp. had a net margin of 18.75% and a return on equity of 33.74%. Equities analysts anticipate that National Research Corp. will post $0.82 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 14th. Investors of record on Friday, September 30th will be issued a $0.48 dividend. This represents a $1.92 dividend on an annualized basis and a dividend yield of 5.31%. The ex-dividend date is Wednesday, September 28th. National Research Corp.’s dividend payout ratio (DPR) is currently 408.52%.
Separately, Zacks Investment Research upgraded shares of National Research Corp. from a “hold” rating to a “buy” rating and set a $37.00 price objective on the stock in a research note on Friday, August 12th.
A hedge fund recently bought a new stake in National Research Corp. stock. WCM Investment Management CA acquired a new position in shares of National Research Corp. (NASDAQ:NRCIB) during the second quarter, according to its most recent filing with the SEC. The firm acquired 46,808 shares of the company’s stock, valued at approximately $1,554,000. WCM Investment Management CA owned approximately 0.19% of National Research Corp. as of its most recent filing with the SEC. Institutional investors and hedge funds own 2.90% of the company’s stock.
About National Research Corp.
National Research Corp. is a business services company in the Health Care Services industry.
Receive News & Ratings for National Research Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research Corp. and related companies with MarketBeat.com's FREE daily email newsletter.